Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing

被引:1
|
作者
Liu, Po-Hong [1 ]
Nair, Rasmi G. [2 ,11 ]
Skinner, Celette Sugg [2 ,3 ]
Murphy, Caitlin C. [4 ]
Kim, Eric J. [2 ]
Ortiz, Cynthia [2 ]
Wang, Lei [2 ]
Hu, Ellen [2 ]
Lykken, Jacquelyn M. [2 ]
Levin, Theodore R. [5 ]
Green, Beverly B. [6 ,7 ]
Hahn, Erin E. [6 ,8 ]
Santini, Noel [1 ,9 ]
Halm, Ethan A. [10 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr, Peter Odonnell Jr Sch Publ Hlth, Dallas, TX USA
[3] Univ Texas Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA
[4] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX USA
[5] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
[6] Kaiser Permanente Bernard J Tyson Sch Med, Dept Hlth Syst Sci, Pasadena, CA USA
[7] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA
[8] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA USA
[9] Parkland Hlth, Dallas, TX USA
[10] Univ Med & Dent New Jersey, Dept Med, New Brunswick, NJ USA
[11] UT Southwestern Med Ctr, Peter ODonnell Jr Sch Publ Hlth, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
SOCIETY TASK-FORCE; FOLLOW-UP; COLONOSCOPY; RECOMMENDATIONS; OUTREACH; TIME;
D O I
10.1158/1055-9965.EPI-23-0507
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Fecal immunochemical test (FIT) is an effective colorectal cancer screening modality. Little is known about prevalence, reasons, and testing after unsatisfactory FIT, or a FIT that cannot be processed by the laboratory due to inadequate stool specimen or incomplete labeling.Methods: Our retrospective cohort study examined unsatisfactory FIT among average-risk individuals aged 50-74 years in a large, integrated, safety-net health system who completed an index FIT from 2010 to 2019. We determined prevalence of unsatisfactory FIT and categorized reasons hierarchically. We used multivariable logistic regression models to identify factors associated with: (i) unsatisfactory FIT; and (ii) subsequent testing within 15 months of the unsatisfactory FIT.Results: Of 56,980 individuals completing an index FIT, 10.2% had an unsatisfactory FIT. Reasons included inadequate specimen (51%), incomplete labeling (27%), old specimen (13%), and broken/leaking container (8%). Unsatisfactory FIT was associated with being male [OR, 1.10; confidence interval (CI), 1.03-1.16], Black (OR, 1.46; CI, 1.33-1.61), Spanish speaking (OR, 1.12; CI, 1.01-1.24), on Medicaid (OR, 1.42; CI, 1.28-1.58), and received FIT by mail (OR, 2.66; CI, 2.35-3.01). Among those with an unsatisfactory FIT, fewer than half (41%) completed a subsequent test within 15 months (median, 4.4 months). Adults aged 50-54 years (OR, 1.16; CI, 1.01-1.39) and those who received FIT by mail (OR, 1.92; CI, 1.49-2.09) were more likely to complete a subsequent test.Conclusions: One in ten returned a FIT that could not be processed, mostly due to patient-related reasons. Fewer than half completed a subsequent test after unsatisfactory FIT.Impact: Screening programs should address these breakdowns such as specimen collection and labeling to improve real-world effectiveness. See related In the Spotlight, p. 183Impact: Screening programs should address these breakdowns such as specimen collection and labeling to improve real-world effectiveness. See related In the Spotlight, p. 183
引用
收藏
页码:215 / 223
页数:9
相关论文
共 50 条
  • [31] Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests
    Meklin, Jannica
    Syrjanen, Kari
    Eskelinen, Matti
    ANTICANCER RESEARCH, 2020, 40 (02) : 575 - 581
  • [32] Colon cancer screening by fecal immunochemical testing in Iran
    Salimzadeh, H.
    Bishehsari, F.
    Sauvaget, C.
    Amani, M.
    Hamzeloo, R.
    Nikfarjam, A.
    Maziar, M.
    Merat, S.
    Delavari, A.
    Malekzadeh, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] Fecal Immunochemical Testing vs Sigmoidoscopy for Cancer Screening
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (04): : 334 - 334
  • [34] Reduced Incidence of Colorectal Cancers With Repeated Screening With Fecal Immunochemical Tests
    Sakata, Yasuhisa
    Sakata, N.
    Nakayama, A.
    Shimoda, R.
    Iwakiri, R.
    Mizuguchi, M.
    Fujimoto, K.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (01) : 217 - 217
  • [35] A comparison of qualitative and quantitative fecal immunochemical tests in the Korean national colorectal cancer screening program
    Park, Mi Jin
    Choi, Kui Son
    Lee, You Kyoung
    Jun, Jae Kwan
    Lee, Hoo-Yeon
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (04) : 461 - 466
  • [36] Analytical Comparison of Three Quantitative Immunochemical Fecal Occult Blood Tests for Colorectal Cancer Screening
    Guittet, Lydia
    Guillaume, Elodie
    Levillain, Romuald
    Beley, Philippe
    Tichet, Jean
    Lantieri, Olivier
    Launoy, Guy
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (07) : 1492 - 1501
  • [37] Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
    Kathy L Flitcroft
    Les M Irwig
    Stacy M Carter
    Glenn P Salkeld
    James A Gillespie
    BMC Gastroenterology, 12
  • [38] Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
    Gies, Anton
    Cuk, Katarina
    Schrotz-King, Petra
    Brenner, Hermann
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2018, 9
  • [39] Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review
    Issaka, Rachel B.
    Avila, Patrick
    Whitaker, Evans
    Bent, Stephen
    Somsouk, Ma
    PREVENTIVE MEDICINE, 2019, 118 : 113 - 121
  • [40] Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average- Risk Population?
    Gini, Andrea
    Selby, Kevin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (10) : 2216 - 2217